Table 1. An overview of the characteristics of the included literatures relevant to GTR.
| Author | Year | Total number of patients | Age (years), mean (± SD) or mean (range) or n [%] | Male, n [%] |
Microscopic/endoscopic, n | Field strength |
NFPT, n [%] |
|---|---|---|---|---|---|---|---|
| Low-field | |||||||
| Ahn et al. (31) | 2008 | 51 | NA | NA | 51/0 | 0.15 T Polestar N20 | NA |
| Berkmann et al. (6) | 2011 | 32 | 57 (±17.9) | 23 [72] | NA | 0.15 T PoleStar N20 | 26 [81] |
| Berkmann et al. (32) | 2012 | 92 | NA | NA | 92/0 | 0.15 T Polestar N20 | 79 [86] |
| Bohinski et al. (8) | 2001 | 29 | 51 (24–74) | 18 [62] | 29/0 | 0.3 T AIRIS II | 22 [76] |
| Fahlbusch et al. (33) | 2001 | 44 | 53 (±14.9) | 29 [66] | 44/0 | 0.2 T Magnetom Open | 39 [89] |
| García et al. (34) | 2017 | 30 | 55 | 13 [43] | 0/30 | 0.15 T Polestar N30 | 15 [50] |
| Hlavica et al. (13) | 2013 | 104 | 59 (22–86) | 57 [55] | 104/0 | 0.15 T Polestar N20 | 104 [100] |
| Jiménez et al. (35) | 2016 | 18 | NA | NA | 0/18 | 0.15 T Polestar N20 | 10 [56] |
| Martin et al. (36) | 1999 | 5 | 36.2 (28–42) | 2 [40] | 5/0 | 0.5 T | 0 [0] |
| Ramm-Pettersen et al. (37) | 2011 | 20 | 54 (23–71) | 13 [65] | 20/0 | 0.5 T Signa SP | 16 [80] |
| Schwartz et al. (38) | 2006 | 15 | 49 (29–67) | 9 [60] | 0/15 | 0.12 T Polestar N10 | 11 [73] |
| Strange et al. (39) | 2020 | 231 | 55.5 (18–88) | 127 [55] | 0/231 | 0.15 T Polestar N20 | 160 [69] |
| Wu et al. (40) | 2009 | 55 | 45.9 (±12.6) | 36 [65] | 55/0 | 0.15 T Polestar N20 | 29 [53] |
| High-field | |||||||
| Berkmann et al. (41) | 2014 | 85 | 55 (±14) | 57 [67] | 85/0 | 1.5 T Magnetom | 85 [100] |
| Chen et al. (23) | 2012 | 13 | NA | NA | 13/0 | 1.5 T Magnetom | NA |
| Dort et al. (42) | 2001 | 15 | 50 (15–80) | 8 [53] | 15/0 | 1.5 T | NA |
| Gohla et al. (43) | 2020 | 42 | 52 (17–79) | 23 [55] | 42/0 | 1.5 T Espree | 35 [83] |
| Hlaváč et al. (44) | 2019 | 111 | 57.3 (22–78) | 75 [68] | 66/45 | 1.5 T Espree | 91 [82] |
| Kuge et al. (45) | 2013 | 35 | 54.3 (±15.5) | 18 [51] | 0/35 | 1.5 T | 27 [77] |
| Li et al. (46) | 2015 | 30 | 36 (21–65) | 13 [43] | 30/0 | 1.5 T Espree | 9 [30] |
| Nimsky et al. (25) | 2004 | 48 | NA | NA | 48/0 | 1.5 T | NA |
| Nimsky et al. (12) | 2006 | 85 | NA | NA | 85/0 | 1.5 T Magnetom | 85 [100] |
| Pal’a et al. (9) | 2017 | 96 | 54 (7–78) | 71 [74] | 68/28 | 1.5 T Espree | 64 [67] |
| Paľa et al. (47) | 2022 | 59 | 57 | 42 [71] | 0/59 | 1.5 T | 42 [71] |
| Pala et al. (48) | 2022 | 190 | 55 | 106 [56] | 88/102 | 1.5 T | NA |
| Paterno' et al. (29) | 2014 | 49 | NA | NA | 0/49 | 1.5 T Espree | 49 [100] |
| Sylvester et al. (30) | 2015 | 156 | NA | NA | 115/41 | 1.5 T Espree | NA |
| Szerlip et al. (49) | 2011 | 53 | 49 (1.8 SEM) | 25 [47] | 53/0 | 1.5 T Espree | 39 [74] |
| Tanei et al. (50) | 2013 | 14 | 37.4 (±11.8) | 2 [14] | 0/14 | 1.5 T Magnetom | 0 [0] |
| Zhang et al. (51) | 2017 | 137 | 7–82 | 73 [53] | 0/137 | 1.5 T Espree | 103 [75] |
| Zhang et al. (52) | 2019 | 133 | 50 (±12) | 61 [46] | 0/133 | 1.5 T Espree | 133 [100] |
| Ultra-high-field | |||||||
| Fomekong et al. (53) | 2014 | 73 | NA | 46 [63] | 73/0 | 3 T Intera | NA |
| Netuka et al. (26) | 2011 | 49 | NA | NA | NA | 3 T | NA |
| Qiu et al. (27) | 2012 | 49 | NA | NA | NA | 3 T Mangetom | NA |
| Serra et al. (11) | 2016 | 51 | 33 [65] | 27 [53] | 0/51 | 3 T Mangetom | 33 [65] |
| Staartjes et al. (10) | 2019 | 95 | 65 [68] | 53 [56] | 0/95 | 3 T Mangetom | 65 [68] |
| Zaidi et al. (14) | 2016 | 20 | 14 [70] | 9 [45] | 0/20 | 3 T Verio | 14 [70] |
GTR, gross total resection; SD, standard deviation; NFPT, nonfunctioning pituitary tumor; NA, not applicable; SEM, standard error of mean.